XTANT MEDICAL HOLDINGS, INC. Payments to Acquire Businesses, Gross
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Payments to Acquire Businesses, Gross of $4.40 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2023-05-04
- XTANT MEDICAL HOLDINGS, INC. payments to acquire businesses, gross for the quarter ending 2023-03-31 was $4.40M.
- XTANT MEDICAL HOLDINGS, INC. payments to acquire businesses, gross for the quarter ending 2015-12-31 was $0.00.
- XTANT MEDICAL HOLDINGS, INC. payments to acquire businesses, gross for the quarter ending 2015-09-30 was $0.00.
- XTANT MEDICAL HOLDINGS, INC. payments to acquire businesses, gross for fiscal 2015 was $250.00K.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2023-03-31 | $4.40M 10-Q · filed 2023-05-04 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $0.00 derived: sum of 2 quarters · filed 2016-03-24 | $250.00K 10-K · filed 2016-03-24 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $250.00K 10-Q · filed 2015-11-16 | ||
| 2015-06-30 | $250.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |